Statement of Retraction: Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer. Issue 6 (1st June 2022)

Record Type:: Journal Article
Title:: Statement of Retraction: Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer. Issue 6 (1st June 2022)
Main Title:: Statement of Retraction: Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer
Abstract:
Is Part Of:: Bioengineered. Volume 13:Issue 6(2022)
Journal:: Bioengineered
Issue:: Volume 13:Issue 6(2022)
Issue Display:: Volume 13, Issue 6 (2022)
Year:: 2022
Volume:: 13
Issue:: 6
Issue Sort Value:: 2022-0013-0006-0000
Page Start:: 14840
Page End:: 14840
Publication Date:: 2022-06-01
Subjects:: Biomedical engineering -- Periodicals
Biotechnology -- Periodicals
Microbiology -- Periodicals
660.6
Journal URLs:: http://www.tandfonline.com/toc/kbie20/current ↗
http://www.landesbioscience.com/journals/bioe/ ↗
http://www.tandfonline.com/ ↗
DOI:: 10.1080/21655979.2022.2143469 ↗
Languages:: English
ISSNs:: 2165-5987
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24491.xml